Circulating anticoagulants in haemophilia

Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.

Journal of immunology (Baltimore, Md. : 1950)·1996

Activation of the hemostatic mechanism during thrombolysis in patients with unstable angina pectoris.

Blood·1995

Determinants of plasma factor VIIa levels in humans.

Blood·1995

Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors.

British journal of haematology·1995

Heightened thrombin formation but normal plasma levels of activated factor VII in patients with acute coronary syndromes.

Arteriosclerosis, thrombosis, and vascular biology·1995

Platelet von Willebrand factor abnormalities in myeloproliferative syndromes.

American journal of hematology·1995

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Multigene panel analysis of connective tissue and vascular genes in patients with a bleeding disorder of unknown cause or a cerebrovascular event.

Research and practice in thrombosis and haemostasis·2026

Platelets in systemic lupus erythematosus: from hemostatic allies to pathogenic drivers.

Frontiers in immunology·2026

Data-augmented machine learning refines the effective-concentration estimate for eculizumab in complement-mediated diseases.

Frontiers in immunology·2026

Bruton's tyrosine kinase inhibitors and cardiovascular risk: a meta-analysis.

European heart journal·2026

Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials.

Journal of thrombosis and thrombolysis·2026

Aggressive versus Conventional Antiplatelet Therapy During Emergent Carotid Stenting in Acute Ischemic Stroke: Balancing Occlusion and Hemorrhage.

AJNR. American journal of neuroradiology·2026

Related Experiment Videos

Circulating anticoagulants in haemophilia

Related Concept Videos

Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.

Activation of the hemostatic mechanism during thrombolysis in patients with unstable angina pectoris.

Determinants of plasma factor VIIa levels in humans.

Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors.

Heightened thrombin formation but normal plasma levels of activated factor VII in patients with acute coronary syndromes.

Platelet von Willebrand factor abnormalities in myeloproliferative syndromes.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Multigene panel analysis of connective tissue and vascular genes in patients with a bleeding disorder of unknown cause or a cerebrovascular event.

Platelets in systemic lupus erythematosus: from hemostatic allies to pathogenic drivers.

Data-augmented machine learning refines the effective-concentration estimate for eculizumab in complement-mediated diseases.

Bruton's tyrosine kinase inhibitors and cardiovascular risk: a meta-analysis.

Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials.

Aggressive versus Conventional Antiplatelet Therapy During Emergent Carotid Stenting in Acute Ischemic Stroke: Balancing Occlusion and Hemorrhage.

Related Experiment Videos

Circulating anticoagulants in haemophilia

Related Concept Videos

Related Articles